The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments proved "life changing". While most patients have 20 days of radiotherapy over ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

A major prostate cancer screening trial aimed at finding the best way to detect the disease has been launched in the UK. The first letters have been sent out from GPs inviting men to join the study, ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

In a pooled analysis of the SPARTAN and TITAN trials, statin use during apalutamide therapy was associated with superior overall survival (OS) but also with an increased risk for grade 3 or greater ...

—These findings suggest that conventional imaging significantly underestimates the extent of disease in high-risk, biochemically recurrent prostate cancer, potentially impacting treatment decisions ...

The UK National Screening Committee’s recent recommendation to introduce prostate cancer screening for men with faulty BRCA ...

Current patterns of care: Referral to palliative care for patients with metastatic gynecologic cancer. Intravenous selenium to prevent oral mucositis in patients with lymphoma or myeloma undergoing ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected ...